← Back to Search

Other

Sana Pain Reliever for Neuropathic Pain

N/A
Waitlist Available
Led By David Putrino, PT, PhD
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline 1(week0); baseline 2 (week 2); post-assessment (week 10); follow up (week 14)
Awards & highlights

Study Summary

This trial is testing a new pain reliever for people with chronic neuropathic pain. The study is done remotely, with four visits over teleconferencing, and the study devices mailed to participants to use at home for 8-14 weeks.

Eligible Conditions
  • Neuropathic Pain
  • Chronic Pain
  • Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline 1(week0); baseline 2 (week 2); post-assessment (week 10); follow up (week 14)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline 1(week0); baseline 2 (week 2); post-assessment (week 10); follow up (week 14) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Neuralgia
Secondary outcome measures
Change in Beck Depression Inventory (BDI)
Change in General Anxiety Disorder 7-item questionnaire (GAD-7)
Mental Depression
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: "Real" SPRExperimental Treatment1 Intervention
Participants will receive the device which will run the "real" Sana Pain Reliever (SPR) protocol and a tablet with a mobile application to record pain levels and other questionnaires
Group II: Sham SPRPlacebo Group1 Intervention
Participants will receive the device which will run a sham SPR protocol and a tablet with a mobile application to record pain levels and other questionnaires
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sana Pain Reliever
2020
N/A
~110

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor
858 Previous Clinical Trials
524,184 Total Patients Enrolled
2 Trials studying Neuropathic Pain
29 Patients Enrolled for Neuropathic Pain
Sana Health, Inc.UNKNOWN
David Putrino, PT, PhDPrincipal InvestigatorIcahn School of Medicine at Mount Sinai
5 Previous Clinical Trials
363 Total Patients Enrolled

Media Library

Sana Pain Reliever (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04280562 — N/A
Neuropathic Pain Research Study Groups: "Real" SPR, Sham SPR
Neuropathic Pain Clinical Trial 2023: Sana Pain Reliever Highlights & Side Effects. Trial Name: NCT04280562 — N/A
Sana Pain Reliever (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04280562 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could you provide information on the current enrollment status of this clinical experiment?

"Indeed, the data hosted on clinicaltrials.gov suggests that this experiment is presently enrolling participants. Originally posted in January of 2020 and recently updated April 22nd 2022 , the medical trial seeks 100 individuals at 1 site."

Answered by AI

Could you provide an estimate of the size of the cohort engaged in this research?

"Affirmative. Clinicaltrials.gov displays that this experiment is actively recruiting, having first been posted on January 16th 2020 and most recently modified on April 22nd 2022. A total of 100 patients are needed for the trial to be conducted at a single medical site."

Answered by AI

Who else is applying?

What state do they live in?
New York
How old are they?
18 - 65
What site did they apply to?
Icahn School of Medicine at Mount Sinai
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Remote Participation (Within USA) Trial of Sana Pain Reliever
David Putrino 2020. "Remote Participation (Within USA) Trial of Sana Pain Reliever". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04280562.
~19 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top